162 related articles for article (PubMed ID: 11912137)
1. Significance of MAD2 expression to mitotic checkpoint control in ovarian cancer cells.
Wang X; Jin DY; Ng RW; Feng H; Wong YC; Cheung AL; Tsao SW
Cancer Res; 2002 Mar; 62(6):1662-8. PubMed ID: 11912137
[TBL] [Abstract][Full Text] [Related]
2. MAD2 expression and its significance in mitotic checkpoint control in testicular germ cell tumour.
Fung MK; Cheung HW; Wong HL; Yuen HF; Ling MT; Chan KW; Wong YC; Cheung AL; Wang X
Biochim Biophys Acta; 2007 Jun; 1773(6):821-32. PubMed ID: 17467818
[TBL] [Abstract][Full Text] [Related]
3. Association of MAD2 expression with mitotic checkpoint competence in hepatoma cells.
Sze KM; Ching YP; Jin DY; Ng IO
J Biomed Sci; 2004; 11(6):920-7. PubMed ID: 15591789
[TBL] [Abstract][Full Text] [Related]
4. Weakened spindle checkpoint with reduced BubR1 expression in paclitaxel-resistant ovarian carcinoma cell line SKOV3-TR30.
Fu Y; Ye D; Chen H; Lu W; Ye F; Xie X
Gynecol Oncol; 2007 Apr; 105(1):66-73. PubMed ID: 17234259
[TBL] [Abstract][Full Text] [Related]
5. MAD2-induced sensitization to vincristine is associated with mitotic arrest and Raf/Bcl-2 phosphorylation in nasopharyngeal carcinoma cells.
Wang X; Jin DY; Wong HL; Feng H; Wong YC; Tsao SW
Oncogene; 2003 Jan; 22(1):109-16. PubMed ID: 12527913
[TBL] [Abstract][Full Text] [Related]
6. Novel Mad2-targeting miR-493-3p controls mitotic fidelity and cancer cells' sensitivity to paclitaxel.
Tambe M; Pruikkonen S; Mäki-Jouppila J; Chen P; Elgaaen BV; Straume AH; Huhtinen K; Cárpen O; Lønning PE; Davidson B; Hautaniemi S; Kallio MJ
Oncotarget; 2016 Mar; 7(11):12267-85. PubMed ID: 26943585
[TBL] [Abstract][Full Text] [Related]
7. p55CDC/hCDC20 mutant induces mitotic catastrophe by inhibiting the MAD2-dependent spindle checkpoint activity in tumor cells.
Sihn CR; Suh EJ; Lee KH; Kim TY; Kim SH
Cancer Lett; 2003 Nov; 201(2):203-10. PubMed ID: 14607335
[TBL] [Abstract][Full Text] [Related]
8. Mitotic arrest deficient 2 expression induces chemosensitization to a DNA-damaging agent, cisplatin, in nasopharyngeal carcinoma cells.
Cheung HW; Jin DY; Ling MT; Wong YC; Wang Q; Tsao SW; Wang X
Cancer Res; 2005 Feb; 65(4):1450-8. PubMed ID: 15735033
[TBL] [Abstract][Full Text] [Related]
9. MAD2DeltaC induces aneuploidy and promotes anchorage-independent growth in human prostate epithelial cells.
To-Ho KW; Cheung HW; Ling MT; Wong YC; Wang X
Oncogene; 2008 Jan; 27(3):347-57. PubMed ID: 17621272
[TBL] [Abstract][Full Text] [Related]
10. The MAD1 1673 G → A polymorphism alters the function of the mitotic spindle assembly checkpoint and is associated with a worse response to induction chemotherapy and sensitivity to treatment in patients with advanced epithelial ovarian cancer.
Santibáñez M; Gallardo D; Morales F; López A; Prada D; Mendoza J; Castro C; de León DC; Oñate LF; Perez D; Mohar A; Herrera LA
Pharmacogenet Genomics; 2013 Apr; 23(4):190-9. PubMed ID: 23407047
[TBL] [Abstract][Full Text] [Related]
11. Dioxin suppresses the checkpoint protein, MAD2, by an aryl hydrocarbon receptor-independent pathway.
Oikawa K; Ohbayashi T; Mimura J; Iwata R; Kameta A; Evine K; Iwaya K; Fujii-Kuriyama Y; Kuroda M; Mukai K
Cancer Res; 2001 Aug; 61(15):5707-9. PubMed ID: 11479202
[TBL] [Abstract][Full Text] [Related]
12. Spindle assembly checkpoint protein expression correlates with cellular proliferation and shorter time to recurrence in ovarian cancer.
McGrogan B; Phelan S; Fitzpatrick P; Maguire A; Prencipe M; Brennan D; Doyle E; O'Grady A; Kay E; Furlong F; McCann A
Hum Pathol; 2014 Jul; 45(7):1509-19. PubMed ID: 24792619
[TBL] [Abstract][Full Text] [Related]
13. Chromosome missegregation and apoptosis in mice lacking the mitotic checkpoint protein Mad2.
Dobles M; Liberal V; Scott ML; Benezra R; Sorger PK
Cell; 2000 Jun; 101(6):635-45. PubMed ID: 10892650
[TBL] [Abstract][Full Text] [Related]
14. Chk1-Mad2 interaction: a crosslink between the DNA damage checkpoint and the mitotic spindle checkpoint.
Chilà R; Celenza C; Lupi M; Damia G; Carrassa L
Cell Cycle; 2013 Apr; 12(7):1083-90. PubMed ID: 23454898
[TBL] [Abstract][Full Text] [Related]
15. p31comet Induces cellular senescence through p21 accumulation and Mad2 disruption.
Yun M; Han YH; Yoon SH; Kim HY; Kim BY; Ju YJ; Kang CM; Jang SH; Chung HY; Lee SJ; Cho MH; Yoon G; Park GH; Kim SH; Lee KH
Mol Cancer Res; 2009 Mar; 7(3):371-82. PubMed ID: 19276188
[TBL] [Abstract][Full Text] [Related]
16. Identification of a human mitotic checkpoint gene: hsMAD2.
Li Y; Benezra R
Science; 1996 Oct; 274(5285):246-8. PubMed ID: 8824189
[TBL] [Abstract][Full Text] [Related]
17. Expression of the mitotic-arrest deficiency 2 is associated with chemotherapy resistance in ovarian serous adenocarcinoma.
Nakano Y; Sumi T; Teramae M; Morishita M; Fukuda T; Terada H; Yoshida H; Matsumoto Y; Yasui T; Ishiko O
Oncol Rep; 2012 Oct; 28(4):1200-4. PubMed ID: 22797604
[TBL] [Abstract][Full Text] [Related]
18. Bone morphogenetic protein (BMP) signaling regulates mitotic checkpoint protein levels in human breast cancer cells.
Yan H; Zhu S; Song C; Liu N; Kang J
Cell Signal; 2012 Apr; 24(4):961-8. PubMed ID: 22234345
[TBL] [Abstract][Full Text] [Related]
19. VHL loss causes spindle misorientation and chromosome instability.
Thoma CR; Toso A; Gutbrodt KL; Reggi SP; Frew IJ; Schraml P; Hergovich A; Moch H; Meraldi P; Krek W
Nat Cell Biol; 2009 Aug; 11(8):994-1001. PubMed ID: 19620968
[TBL] [Abstract][Full Text] [Related]
20. Cellular senescence induced by aberrant MAD2 levels impacts on paclitaxel responsiveness in vitro.
Prencipe M; Fitzpatrick P; Gorman S; Tosetto M; Klinger R; Furlong F; Harrison M; O'Connor D; Roninson IB; O'Sullivan J; McCann A
Br J Cancer; 2009 Dec; 101(11):1900-8. PubMed ID: 19935801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
